Navigation Links
Under the Microscope: 'Micro IVF'

MDs Debate Effectiveness of 'Micro IVF,' also referred to as 'Mini IVF' or 'Minimal Stimulation IVF' at

LOS ANGELES, April 28 /PRNewswire/ -- Several esteemed reproductive endocrinologists are now weighing in at on the subject of the new "Micro IVF," also called "Mini IVF" or "Minimal Stimulation IVF." FertilityTies is the only comprehensive online community and social network providing 24-7-365 support on fertility matters, connecting members with peers as well as accredited medical professionals. The physicians who have expressed their opinions discuss the effectiveness of a procedure that was designed to be recession-savvy because it cuts down on time and medication costs required for conventional IVF.

Micro IVF can be described as taking only oral fertility medications with or without minimal use of injectable gonadotropins when going through In Vitro fertilization. The process then proceeds in similar fashion to conventional IVF with egg retrieval, fertilization, embryo culture and embryo transfer. This new protocol is said to not only cut down on costs, but to diminish risks of multiple births.

Following are the opinions expressed by Reproductive Endocrinologists at, (It should be noted that FertilityTies does not promote specific fertility treatment but provides information from all sides so members can be informed):

I. Dr. Rudy Quintero, M.D., F.A.C.O.G. (on the CON side of the debate) Founder and Medical Director of C.A.R.E. Fertility in Los Angeles, CA.

"IVF over the past twenty years has evolved and been optimized from a point where pregnancy rates were at best quoted to be 10% back then to about 50% today. We have become better with stimulation protocols and techniques over this time period. Nevertheless, this success has unintended consequences including the possibility of embryo overproduction and multiple births.

Minimal Stimulation IVF is currently being touted as a solution for this, and we all hope that it soon will be. However, we lack sufficient data from clinical trials to support its use. In one of the better trials to date from Pelinck et al (Netherlands), an 8% pregnancy rate was noted, with a 20.8% pregnancy rate after three attempts with Minimal Stimulation IVF. Some authors have published success rates of up to 40% using Minimal Stimulation IVF, but percentages may be influenced by bias and other study errors due to their retrospective design.

More data needs to become available to truly assess the success of this protocol for different types of patients."

II. Dr. David Kreiner, MD, F.A.C.O.G. (PRO Micro IVF), Medical Director of East Coast Fertility in NYC.

"Micro IVF is a great way to assist patients with achieving their goal of having a single baby while minimizing their risk of complications such as multiple pregnancy, hyper-stimulation syndrome or producing financial hardship. Its lower cost and risk should outweigh diminished pregnancy rate which for young high responders and older poor responders will be minimal. The reason these groups would see a minimal decrease in success is that the younger high responders have a higher implantation rate per embryo and do not need as many embryos to produce the healthy one that will result in a baby. The older poor responders do not make extra embryos with aggressive stimulation and have nothing to gain by adding gonadotropins in a conventional IVF cycle."

III. Dr. Eva Littman, M.D., F.A.C.O.G. (CON)

Founder & Medical Director of Red Rock Fertility in Las Vegas.

"My biggest fear is that this procedure will be misused by couples and patients who require conventional IVF, but because of the economy they opt for the lower price and subsequently, the lower chance of success. It worries me that in order to try to save money, patients may fall for a 'gimmick' and use up funds that could have gone towards a real chance at success."

For more information about "Micro IVF" and the debate surrounding the new protocol, visit Those interested in attending FertilityTies' June 6th convention at The Hilton New York Hotel, where more information about "Micro IVF" and other timely topics (including Infertility Treatments & Ethics in the Wake of the Octuplets, The Controversy of "Designer Babies," Effectiveness of Egg Freezing, Pre-Implantation Genetic Diagnostic/embryo screening, and Benefits of Acupuncture & Herbal Medicines for Fertility) will be discussed, can sign up at the web site.

Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
2. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
3. MultiVu Video Feed: Allergan, Inc. Partners With "Project Runway" Designer Kara Saun and Gen Art Fresh Faces In Fashion to Raise Awareness About Excessive Underarm Sweating
4. GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis
5. AMDLs Jade Pharmaceutical Subsidiary Announces New Product Strategy; Six New Products, Including One With Sales Projected at Upwards of $10 Million, Under Development
6. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
7. Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT
8. Top Spin Appoints Yaron Tal President and Chief Executive Officer, Erez Golan, TopSpin Medicals Founder and Current Chief Executive Officer, Will Continue as a Board Member and Consultant
9. Genstructs Andrea Matthews Selected for Mass High Techs People to Watch Under 30
10. Researchers underscore limitations of genetic ancestry tests
11. Leading Edge Research Underway in Fall Prevention for Seniors
Post Your Comments:
(Date:11/25/2015)... 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... and CEO of Neurocrine Biosciences, will be presenting at ... New York . .   ... approximately 5 minutes prior to the presentation to download ... presentation will be available on the website approximately one ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ... today reported financial results for the quarter ended ... expressed in Canadian dollars and presented under International ... United States ," said Andrew Rae ... advancements regarding iCo-008 are not only value enriching ...
(Date:11/24/2015)... 24, 2015 --> ... report "Oligonucleotide Synthesis Market by Product & Services (Primer, ... Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic ... the market is expected to reach USD 1,918.6 Million ... a CAGR of 10.1% during the forecast period. ...
Breaking Biology Technology:
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
(Date:11/9/2015)... Calif. , Nov. 9, 2015  Synaptics Inc. ... interface solutions, today announced broader entry into the automotive ... solutions that match the pace of consumer electronics human ... biometric sensors are ideal for the automotive industry and ... Europe , ...
(Date:10/29/2015)... 29, 2015   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that it ... (MHTA) as one of only three finalists for a ... Small and Growing" category. The Tekne Awards honor ... superior technology innovation and leadership. iMedNet™ ...
Breaking Biology News(10 mins):